药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Almotriptan
Ritanserin
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Ritanserin.
Almotriptan
Indalpine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Indalpine.
Almotriptan
Levomilnacipran
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Levomilnacipran.
Almotriptan
Seproxetine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Seproxetine.
Almotriptan
Desvenlafaxine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Desvenlafaxine.
Almotriptan
Milnacipran
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Milnacipran.
Almotriptan
Dapoxetine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Dapoxetine.
Almotriptan
Zimelidine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Zimelidine.
Almotriptan
Sibutramine
The risk or severity of adverse effects can be increased when gamma-Hydroxybutyric acid is combined with Sibutramine.
Almotriptan
Thalidomide
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.
Almotriptan
Tapentadol
Tapentadol may increase the central nervous system depressant (CNS depressant) activities of gamma-Hydroxybutyric acid.
Almotriptan
Suvorexant
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.
Almotriptan
Rufinamide
The risk or severity of adverse effects can be increased when Rufinamide is combined with gamma-Hydroxybutyric acid.
Almotriptan
Rotigotine
gamma-Hydroxybutyric acid may increase the sedative activities of Rotigotine.
Almotriptan
Perampanel
Perampanel may increase the central nervous system depressant (CNS depressant) activities of gamma-Hydroxybutyric acid.
Almotriptan
Paraldehyde
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.
Almotriptan
Orphenadrine
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.
Almotriptan
Methotrimeprazine
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.
Almotriptan
Hydrocodone
gamma-Hydroxybutyric acid may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.
Anileridine
Satralizumab
The serum concentration of Antipyrine can be decreased when it is combined with Satralizumab.